Middle East & Africa Congestive Heart Failure Drugs Market Size & Outlook

The congestive heart failure drugs market in Middle East & Africa is expected to reach a projected revenue of US$ 556.4 million by 2030. A compound annual growth rate of 11.6% is expected of Middle East & Africa congestive heart failure drugs market from 2022 to 2030.

Revenue, 2021 (US$M)
$207.4
Forecast, 2030 (US$M)
$556.4
CAGR, 2022 - 2030
11.6%
Report Coverage
Middle East & Africa

Middle East & Africa congestive heart failure drugs market, 2018-2030 (US$M)

Middle

Related Markets

MEA congestive heart failure drugs market highlights

  • The MEA congestive heart failure drugs market generated a revenue of USD 207.4 million in 2021.
  • The market is expected to grow at a CAGR of 11.6% from 2022 to 2030.
  • In terms of segment, ace inhibitors was the largest revenue generating drug type in 2021.
  • Other Drug Types (Statins, including pipeline) is the most lucrative drug type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2022 to 2030.

MEA data book summary

Market revenue in 2021USD 207.4 million
Market revenue in 2030USD 556.4 million
Growth rate11.6% (CAGR from 2021 to 2030)
Largest segmentAce inhibitors
Fastest growing segmentOther Drug Types (Statins, including pipeline)
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone antagonists, Inotropes, Other Drug Types (Statins, including pipeline)
Key market players worldwideBayer AG, Novartis AG ADR, Merck & Co Inc, AstraZeneca PLC ADR, Bristol-Myers Squibb Co, Amgen Inc, Boehringer Ingelheim, Pfizer Inc, Johnson & Johnson, Otsuka Pharmaceutical, Eli Lilly and Co, Novo Nordisk A/S ADR

Other key industry trends

  • In terms of revenue, MEA region accounted for 3.4% of the global congestive heart failure drugs market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 5,084.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Congestive Heart Failure Drugs Market Companies

Name Profile # Employees HQ Website

Middle East & Africa congestive heart failure drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure drugs market will help companies and investors design strategic landscapes.


Ace inhibitors was the largest segment with a revenue share of 32.88% in 2021. Horizon Databook has segmented the Middle East & Africa congestive heart failure drugs market based on ace inhibitors, angiotensin 2 receptor blockers, beta blockers, diuretics, aldosterone antagonists, inotropes, other drug types (statins, including pipeline) covering the revenue growth of each sub-segment from 2018 to 2030.


  • Middle East & Africa Congestive Heart Failure Drugs Drug Type Outlook (Revenue, USD Million, 2018-2030)
    • ACE Inhibitors
    • Angiotensin 2 Receptor Blockers
    • Beta Blockers
    • Diuretics
    • Aldosterone antagonists
    • Inotropes
    • Other Drug Types (Statins, including pipeline)
  • Middle East & Africa Congestive Heart Failure Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Reasons to subscribe to Middle East & Africa congestive heart failure drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa congestive heart failure drugs market databook

  • Our clientele includes a mix of congestive heart failure drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa congestive heart failure drugs market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa congestive heart failure drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA congestive heart failure drugs market report size, by country, 2018-2030 (US$M)

Middle East & Africa Congestive Heart Failure Drugs Market Share, 2021 & 2030 (US$M)

MEA congestive heart failure drugs market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more